Research Summary
Bimatoprost (CAS 155206-00-1), also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.
According to DIResearch's in-depth investigation and research, the global Bimatoprost (CAS 155206-00-1) market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Bimatoprost (CAS 155206-00-1) include Shanghai Qiao Chemical Science, Hubei Marvel-Bio Medicine, Hubei Kangbaotai Fine Chemical, Shanghai Techwell Biopharmaceutical, Allergan etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Bimatoprost (CAS 155206-00-1). Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Bimatoprost (CAS 155206-00-1) market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Bimatoprost (CAS 155206-00-1) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bimatoprost (CAS 155206-00-1) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Bimatoprost (CAS 155206-00-1) Include:
Shanghai Qiao Chemical Science
Hubei Marvel-Bio Medicine
Hubei Kangbaotai Fine Chemical
Shanghai Techwell Biopharmaceutical
Allergan
Bimatoprost (CAS 155206-00-1) Product Segment Include:
98% Purity
99% Purity
Bimatoprost (CAS 155206-00-1) Product Application Include:
Medical Products
Personal Care
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Bimatoprost (CAS 155206-00-1) Industry PESTEL Analysis
Chapter 3: Global Bimatoprost (CAS 155206-00-1) Industry Porter's Five Forces Analysis
Chapter 4: Global Bimatoprost (CAS 155206-00-1) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Bimatoprost (CAS 155206-00-1) Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Bimatoprost (CAS 155206-00-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Bimatoprost (CAS 155206-00-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Bimatoprost (CAS 155206-00-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Bimatoprost (CAS 155206-00-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Bimatoprost (CAS 155206-00-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Bimatoprost (CAS 155206-00-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Bimatoprost (CAS 155206-00-1) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Bimatoprost (CAS 155206-00-1) Market Overview 1.1 Product Definition and Statistical Scope 1.2 Bimatoprost (CAS 155206-00-1) Product by Type 1.2.1 Global Bimatoprost (CAS 155206-00-1) Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 98% Purity 1.2.3 99% Purity 1.3 Bimatoprost (CAS 155206-00-1) Product by Application 1.3.1 Global Bimatoprost (CAS 155206-00-1) Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Medical Products 1.3.3 Personal Care 1.3.4 Other 1.4 Global Bimatoprost (CAS 155206-00-1) Market Revenue and Sales Analysis 1.4.1 Global Bimatoprost (CAS 155206-00-1) Market Size Analysis (2019-2030) 1.4.2 Global Bimatoprost (CAS 155206-00-1) Market Sales Analysis (2019-2030) 1.4.3 Global Bimatoprost (CAS 155206-00-1) Market Sales Price Trend Analysis (2019-2030) 1.5 Bimatoprost (CAS 155206-00-1) Market Development Status and Trends 1.5.1 Bimatoprost (CAS 155206-00-1) Industry Development Status Analysis 1.5.2 Bimatoprost (CAS 155206-00-1) Industry Development Trends Analysis 2 Bimatoprost (CAS 155206-00-1) Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Bimatoprost (CAS 155206-00-1) Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Bimatoprost (CAS 155206-00-1) Market Analysis by Regions 4.1 Bimatoprost (CAS 155206-00-1) Overall Market: 2023 VS 2024 VS 2030 4.2 Global Bimatoprost (CAS 155206-00-1) Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Bimatoprost (CAS 155206-00-1) Revenue and Market Share by Region (2019-2024) 4.2.2 Global Bimatoprost (CAS 155206-00-1) Revenue Forecast by Region (2025-2030) 4.3 Global Bimatoprost (CAS 155206-00-1) Sales and Forecast Analysis (2019-2030) 4.3.1 Global Bimatoprost (CAS 155206-00-1) Sales and Market Share by Region (2019-2024) 4.3.2 Global Bimatoprost (CAS 155206-00-1) Sales Forecast by Region (2025-2030) 4.4 Global Bimatoprost (CAS 155206-00-1) Sales Price Trend Analysis (2019-2030) 5 Global Bimatoprost (CAS 155206-00-1) Market Size by Type and Application 5.1 Global Bimatoprost (CAS 155206-00-1) Market Size by Type 5.1.1 Global Bimatoprost (CAS 155206-00-1) Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Bimatoprost (CAS 155206-00-1) Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Bimatoprost (CAS 155206-00-1) Market Size by Application 5.2.1 Global Bimatoprost (CAS 155206-00-1) Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Bimatoprost (CAS 155206-00-1) Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Bimatoprost (CAS 155206-00-1) Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Bimatoprost (CAS 155206-00-1) Market Size by Type 6.3.1 North America Bimatoprost (CAS 155206-00-1) Sales by Type (2019-2030) 6.3.2 North America Bimatoprost (CAS 155206-00-1) Revenue by Type (2019-2030) 6.4 North America Bimatoprost (CAS 155206-00-1) Market Size by Application 6.4.1 North America Bimatoprost (CAS 155206-00-1) Sales by Application (2019-2030) 6.4.2 North America Bimatoprost (CAS 155206-00-1) Revenue by Application (2019-2030) 6.5 North America Bimatoprost (CAS 155206-00-1) Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Bimatoprost (CAS 155206-00-1) Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Bimatoprost (CAS 155206-00-1) Market Size by Type 7.3.1 Europe Bimatoprost (CAS 155206-00-1) Sales by Type (2019-2030) 7.3.2 Europe Bimatoprost (CAS 155206-00-1) Revenue by Type (2019-2030) 7.4 Europe Bimatoprost (CAS 155206-00-1) Market Size by Application 7.4.1 Europe Bimatoprost (CAS 155206-00-1) Sales by Application (2019-2030) 7.4.2 ? Europe Bimatoprost (CAS 155206-00-1) Revenue by Application (2019-2030) 7.5 Europe Bimatoprost (CAS 155206-00-1) Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Bimatoprost (CAS 155206-00-1) Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Bimatoprost (CAS 155206-00-1) Market Size by Type 8.3.1 China Bimatoprost (CAS 155206-00-1) Sales by Type (2019-2030) 8.3.2 China Bimatoprost (CAS 155206-00-1) Revenue by Type (2019-2030) 8.4 China Bimatoprost (CAS 155206-00-1) Market Size by Application 8.4.1 China Bimatoprost (CAS 155206-00-1) Sales by Application (2019-2030) 8.4.2 China Bimatoprost (CAS 155206-00-1) Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Bimatoprost (CAS 155206-00-1) Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Bimatoprost (CAS 155206-00-1) Market Size by Type 9.3.1 APAC (excl. China) Bimatoprost (CAS 155206-00-1) Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Bimatoprost (CAS 155206-00-1) Revenue by Type (2019-2030) 9.4 APAC (excl. China) Bimatoprost (CAS 155206-00-1) Market Size by Application 9.4.1 APAC (excl. China) Bimatoprost (CAS 155206-00-1) Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Bimatoprost (CAS 155206-00-1) Revenue by Application (2019-2030) 9.5 APAC (excl. China) Bimatoprost (CAS 155206-00-1) Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Bimatoprost (CAS 155206-00-1) Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Bimatoprost (CAS 155206-00-1) Market Size by Type 10.3.1 Latin America Bimatoprost (CAS 155206-00-1) Sales by Type (2019-2030) 10.3.2 Latin America Bimatoprost (CAS 155206-00-1) Revenue by Type (2019-2030) 10.4 Latin America Bimatoprost (CAS 155206-00-1) Market Size by Application 10.4.1 Latin America Bimatoprost (CAS 155206-00-1) Sales by Application (2019-2030) 10.4.2 Latin America Bimatoprost (CAS 155206-00-1) Revenue by Application (2019-2030) 10.5 Latin America Bimatoprost (CAS 155206-00-1) Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Bimatoprost (CAS 155206-00-1) Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Bimatoprost (CAS 155206-00-1) Market Size by Type 11.3.1 Middle East & Africa Bimatoprost (CAS 155206-00-1) Sales by Type (2019-2030) 11.3.2 Middle East & Africa Bimatoprost (CAS 155206-00-1) Revenue by Type (2019-2030) 11.4 Middle East & Africa Bimatoprost (CAS 155206-00-1) Market Size by Application 11.4.1 Middle East & Africa Bimatoprost (CAS 155206-00-1) Sales by Application (2019-2030) 11.4.2 Middle East & Africa Bimatoprost (CAS 155206-00-1) Revenue by Application (2019-2030) 11.5 Middle East & Africa Bimatoprost (CAS 155206-00-1) Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Bimatoprost (CAS 155206-00-1) Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Bimatoprost (CAS 155206-00-1) Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Bimatoprost (CAS 155206-00-1) Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Bimatoprost (CAS 155206-00-1) Average Sales Price by Manufacturers (2020-2024) 12.2 Bimatoprost (CAS 155206-00-1) Competitive Landscape Analysis and Market Dynamic 12.2.1 Bimatoprost (CAS 155206-00-1) Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Shanghai Qiao Chemical Science 13.1.1 Shanghai Qiao Chemical Science Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Shanghai Qiao Chemical Science Bimatoprost (CAS 155206-00-1) Product Portfolio 13.1.3 Shanghai Qiao Chemical Science Bimatoprost (CAS 155206-00-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Hubei Marvel-Bio Medicine 13.2.1 Hubei Marvel-Bio Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Hubei Marvel-Bio Medicine Bimatoprost (CAS 155206-00-1) Product Portfolio 13.2.3 Hubei Marvel-Bio Medicine Bimatoprost (CAS 155206-00-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Hubei Kangbaotai Fine Chemical 13.3.1 Hubei Kangbaotai Fine Chemical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Hubei Kangbaotai Fine Chemical Bimatoprost (CAS 155206-00-1) Product Portfolio 13.3.3 Hubei Kangbaotai Fine Chemical Bimatoprost (CAS 155206-00-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Shanghai Techwell Biopharmaceutical 13.4.1 Shanghai Techwell Biopharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Shanghai Techwell Biopharmaceutical Bimatoprost (CAS 155206-00-1) Product Portfolio 13.4.3 Shanghai Techwell Biopharmaceutical Bimatoprost (CAS 155206-00-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Allergan 13.5.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Allergan Bimatoprost (CAS 155206-00-1) Product Portfolio 13.5.3 Allergan Bimatoprost (CAS 155206-00-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Bimatoprost (CAS 155206-00-1) Industry Chain Analysis 14.2 Bimatoprost (CAS 155206-00-1) Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Bimatoprost (CAS 155206-00-1) Typical Downstream Customers 14.4 Bimatoprost (CAS 155206-00-1) Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support